会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • DC107 DERIVATIVES
    • DC107衍生物
    • WO1997000260A1
    • 1997-01-03
    • PCT/JP1996001646
    • 1996-06-14
    • KYOWA HAKKO KOGYO CO., LTD.KANDA, YutakaSAITOH, YutakaSAITO, HiromitsuASHIZAWA, TadashiSUGIYAMA, KazuyoGOMI, KatsushigeKAKITA, ShingoTAKAHASHI, YuichiMURAKATA, Chikara
    • KYOWA HAKKO KOGYO CO., LTD.
    • C07D513/08
    • C07D513/08
    • DC107 derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, wherein R represents hydrogen, lower alkoxyalkyl, aralkyloxyalkyl, lower alkoxyalkoxyalkyl, lower alkoxyalkoxyalkoxyalkyl, aralkyl, tetrahydropyranyl, COR , etc.; R represents hydrogen or COR ; R represents lower alkyl, lower alkenyl, aralkyl optionally substituted by optionally substituted aryl, lower alkoxyalkyl, aralkyloxyalkyl, optionally substituted aryloxyalkyl, lower alkoxycarbonylalkyl, lower alkanoyloxy-alkyl, alicyclic alkanoyloxyalkyl, etc., or R forms a single bond together with Y; Y forms a single bond together with R or Z; Z represents hydrogen or forms a single bond together with Y; and W represents oxygen or NR , excluding the compound (DC107) wherein R , R and Z are each hydrogen, R forms a single bond together with Y and W is oxygen.
    • 由通式(I)表示的DC107衍生物或其药学上可接受的盐,其中R 1表示氢,低级烷氧基烷基,芳烷氧基烷基,低级烷氧基烷氧基烷基,低级烷氧基烷氧基烷氧基烷基,芳烷基,四氢吡喃基,COR4等; R 2表示氢或COR 5; R 3表示低级烷基,低级烯基,任选被任意取代的芳基取代的芳烷基,低级烷氧基烷基,芳烷氧基烷基,任选取代的芳氧基烷基,低级烷氧基羰基烷基,低级烷酰氧基 - 烷基,脂环族烷酰氧基烷基等,或R 3形成单 与Y键合; Y与R 3或Z一起形成单键; Z表示氢或与Y一起形成单键; W表示氧或NR 6,不包括其中R 1,R 2和Z各自为氢的化合物(DC107),R 3与Y一起形成单键,W是氧。
    • 6. 发明申请
    • PROPENONE DERIVATIVE
    • 丙酮衍生物
    • WO1995014003A1
    • 1995-05-26
    • PCT/JP1994001934
    • 1994-11-16
    • KYOWA HAKKO KOGYO CO., LTD.IKEDA, Shun-ichiKIMURA, UichiroASHIZAWA, TadashiGOMI, KatsushigeSAITO, HiromitsuKASAI, Masaji
    • KYOWA HAKKO KOGYO CO., LTD.
    • C07D209/12
    • C07D401/06C07D209/12C07D209/30C07D405/06
    • A propenone derivative represented by general formula (I) and a pharmacologically acceptable salt thereof, wherein R represents hydrogen, lower alkyl, lower alkanoyl, lower alkoxycarbonyl, lower alkylsulfonyl, aralkyl, (un)substituted aroyl, (un)substituted arylsulfonyl, (un)substituted heteroarylcarbonyl, (un)substituted heteroarylsulfonyl, diglycolyl or a group of formula (a), R represents hydrogen, lower alkyl, halogen, (un)substituted aryl or (un)substituted heteroaryl; R represents hydrogen, lower alkyl or (un)substituted aryl; and R , R , R and R represent each independently hydrogen, lower alkyl, lower alkoxy, aralkyloxy, hydroxy, nitro, halogen, trifluoromethyl or -NR R , wherein R and R represent each independently hydrogen, lower alkyl, lower alkanoyl, lower alkoxycarbonyl or (un)substituted aroyl.
    • 由通式(I)表示的丙烯酮衍生物及其药理学可接受的盐,其中R 1表示氢,低级烷基,低级烷酰基,低级烷氧基羰基,低级烷基磺酰基,芳烷基,(取代的)取代的芳酰基,(未)取代的芳基磺酰基 ,(un)取代的杂芳基羰基,(un)取代的杂芳基磺酰基,二油基或式(a)的基团,R 2表示氢,低级烷基,卤素,(未)取代的芳基或(取代) R 3表示氢,低级烷基或(未)取代的芳基; R 4,R 5,R 6和R 7各自独立地表示氢,低级烷基,低级烷氧基,芳烷氧基,羟基,硝基,卤素,三氟甲基或-NR 8 R 9。 其中R 8和R 9各自独立地表示氢,低级烷基,低级烷酰基,低级烷氧基羰基或(取代的)取代的芳酰基。
    • 9. 发明申请
    • INDOLE DERIVATIVE
    • WO1995019343A1
    • 1995-07-20
    • PCT/JP1995000019
    • 1995-01-11
    • KYOWA HAKKO KOGYO CO., LTD.MACHII, DaisukeTAKAI, HarukiKOSAKA, NobuoSEO, HisakatsuSUGIYAMA, TomomiNAKAMURA, JojiISHIDA, HiroyukiGOMI, KatsushigeSATO, SoichiroUCHII, Masako
    • KYOWA HAKKO KOGYO CO., LTD.
    • C07D209/42
    • C07D209/42
    • An indole derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R and R may be the same or different and each represents hydrogen, lower alkyl, -(CH2)n-OR (R representing hydrogen or lower alkyl, and n representing an integer of 1 to 6), or -(CH2)m-NR R (wherein R and R may be the same or different and each represents hydrogen or lower alkyl, or alternatively R and R are combined to represent, together with the nitrogen atom to which they are bonded, an (un)substituted heteroalicyclic group, and m represents an integer of 2 to 6); R represents hydrogen, lower alkyl or -(CH2)p-NR R (wherein R and R may be the same or different and each represents hydrogen or lower alkyl, or alternatively R and R are combined to represent, together with the nitrogen atom to which they are bonded, an (un)substituted heteroalicyclic group, and p represents an integer of 2 to 6); and R and R may be the same or different and each represents hydrogen, lower alkyl, cycloalkyl, (un)substituted aryl or (un)substituted heterocycle, or alternatively R and R are combined to represent, together with the nitrogen atom to which they are bonded, an (un)substituted heteroalicyclic group.
    • 由通式(I)表示的吲哚衍生物或其药理学上可接受的盐,其中R 1和R 2可以相同或不同,各自表示氢,低级烷基, - (CH 2)n -OR 6 (R 6表示氢或低级烷基,n表示1〜6的整数)或 - (CH 2)m -NR 7 R 8(其中R 7和R 8可以 相同或不同,各自表示氢或低级烷基,或者R 7和R 8与它们所键合的氮原子一起代表与(un)取代的杂脂环基,m 表示2〜6的整数); R 3表示氢,低级烷基或 - (CH 2)p -NR NR 9 R 10(其中R 9和R 10可以相同或不同,各自表示氢或低级烷基,或 或者R 9和R 10与它们所键合的氮原子一起代表(取代的)杂脂环基,p表示2〜6的整数)。 R 4和R 5可以相同或不同,各自表示氢,低级烷基,环烷基,(未)取代的芳基或(未)取代的杂环,或者R 4和R 5分别为 与它们所键合的氮原子一起表示((un)取代的杂脂环基。